Not applicableEnded earlyNCT02016222What this trial is testingTear Analysis in the Diagnosis of Multiple SclerosisWho this might be right forPrimary Progressive Multiple Sclerosis Lille Catholic University 80
Not applicableLooking for participantsNCT07426991What this trial is testingCognitive Performance, Sleep Disturbances and Fatigue in Multiple SclerosisWho this might be right forMultiple SclerosisRemitting-Relapsing Multiple SclerosisPrimary Progressive Multiple Sclerosis+3 more Heinrich-Heine University, Duesseldorf 837
Early research (Phase 1)Looking for participantsNCT06592703What this trial is testingAllogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis Rennes University Hospital 10
Early research (Phase 1)Study completedNCT03493841What this trial is testingComparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple SclerosisWho this might be right forMultiple SclerosisProgressive Multiple SclerosisSecondary Progressive Multiple Sclerosis+1 more Rebecca Spain 20
Testing effectiveness (Phase 2)Study completedNCT01450488What this trial is testingMasitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis AB Science 35
Not applicableUnknownNCT06025903What this trial is testingAssessing the Role of Mitochondrial Dysfunction in Primary Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis IRCCS San Raffaele 140
Large-scale testing (Phase 3)Study completedNCT05232825What this trial is testingA Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple SclerosisWho this might be right forRelapsing Multiple SclerosisPrimary Progressive Multiple Sclerosis Hoffmann-La Roche 236
Not applicableStudy completedNCT03653585What this trial is testingCortical Lesions in Patients With Multiple SclerosisWho this might be right forMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive Danish Research Centre for Magnetic Resonance 80
Not applicableNo Longer AvailableNCT02807285What this trial is testingExpanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis Genentech, Inc.
Not applicableStudy completedNCT01848327What this trial is testingCaprylic Triglyceride for Treatment of Cognitive Impairments in Multiple SclerosisWho this might be right forRelapsing Remitting MSSecondary Progressive MSPrimary Progressive MS University of Miami 124
Not applicableLooking for participantsNCT05748015What this trial is testingDefinition of Autonomic Nervous System Involvement in Patients With Multiple SclerosisWho this might be right forMultiple Sclerosis Istituti Clinici Scientifici Maugeri SpA 60
Not applicableStudy completedNCT02549703What this trial is testingMitochondrial Dysfunction and Disease ProgressionWho this might be right forClinically Isolated SyndromeRelapsing-Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis+1 more Icahn School of Medicine at Mount Sinai 47
Not applicableStudy completedNCT03983681What this trial is testingEvaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MSWho this might be right forMultiple Sclerosis Kessler Foundation 81
Post-approval studies (Phase 4)Active Not RecruitingNCT07483450What this trial is testingEvaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple SclerosisWho this might be right forRelapsing Multiple SclerosisPrimary Progressive Multiple Sclerosis Hoffmann-La Roche 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05893225What this trial is testingMetformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And NeurodegenerationWho this might be right forMultiple SclerosisPrimary Progressive Multiple SclerosisSecondary-progressive Multiple Sclerosis University Hospital, Antwerp 120
Not applicableUnknownNCT06320444What this trial is testingNon-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone DiseaseWho this might be right forMotor Neuron Disease, Amyotrophic Lateral SclerosisMotor Neuron Disease Progressive Spinal Muscle AtrophyPrimary Lateral Sclerosis+2 more University of Dublin, Trinity College 240
Large-scale testing (Phase 3)Ended earlyNCT00731692What this trial is testingThis Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.Who this might be right forPrimary Progressive Multiple Sclerosis Novartis Pharmaceuticals 970
Not applicableNot Yet RecruitingNCT07280871What this trial is testingClinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health CareWho this might be right forMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic ProgressiveClinically Isolated Syndrome+1 more Luxembourg Institute of Health 100
Not applicableStudy completedNCT02305264What this trial is testingImaging of Intracerebral Inflammation in MSWho this might be right forMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive Assistance Publique - Hôpitaux de Paris 61
Not applicableStudy completedNCT05974839What this trial is testingEffect of Ocrelizumab on Cortical Lesion Accumulation in Patients With PPMS (ORATORIO-Cortical)Who this might be right forPrimary Progressive Multiple Sclerosis State University of New York at Buffalo 732